← Back to directory

Masaki Otagiri

Researcher Next ID · RN-041718

Researcher · Biochemistry, Genetics and Molecular Biology

Sojo University

Kumamoto, Czechia

Accepting doctoral researchersFunding unknown
Works count
724
Citation count
22,737
H-index
64
i10-index
429

Research interests

Biochemistry, Genetics and Molecular Biology
Chemistry
Medicine
Pharmacology, Toxicology and Pharmaceutics
Protein Interaction Studies and Fluorescence Analysis
Drug Transport and Resistance Mechanisms
Hemoglobin structure and function
Drug Solubulity and Delivery Systems
Analytical Chemistry and Chromatography

Publications

  • Antioxidant activities of chitosans and its derivatives in in vitro and in vivo studies

    Carbohydrate Polymers · 2018 · 10.1016/j.carbpol.2018.07.016

  • Antioxidant activities of chitosans and its derivatives in in vitro and in vivo studies

    Carbohydrate Polymers · 2018 · 10.1016/j.carbpol.2018.07.016

  • Potential therapeutic interventions for chronic kidney disease‐associated sarcopenia via indoxyl sulfate‐induced mitochondrial dysfunction

    Journal of Cachexia Sarcopenia and Muscle · 2017 · 10.1002/jcsm.12202

  • Potential therapeutic interventions for chronic kidney disease‐associated sarcopenia via indoxyl sulfate‐induced mitochondrial dysfunction

    Journal of Cachexia Sarcopenia and Muscle · 2017 · 10.1002/jcsm.12202

  • Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1

    Scientific Reports · 2016 · https://doi.org/10.1038/srep32084

  • Cys34-Cysteinylated Human Serum Albumin Is a Sensitive Plasma Marker in Oxidative Stress-Related Chronic Diseases

    PLoS ONE · 2014 · 10.1371/journal.pone.0085216

  • Albumin–drug interaction and its clinical implication

    Biochimica et Biophysica Acta (BBA) - General Subjects · 2013 · https://doi.org/10.1016/j.bbagen.2013.05.005

  • p -Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase

    Kidney International · 2013 · https://doi.org/10.1038/ki.2012.448

  • Redox properties of serum albumin

    Biochimica et Biophysica Acta (BBA) - General Subjects · 2013 · 10.1016/j.bbagen.2013.04.036

  • Antioxidant properties of some different molecular weight chitosans

    Carbohydrate Research · 2009 · 10.1016/j.carres.2009.05.006

  • Antioxidant properties of some different molecular weight chitosans

    Carbohydrate Research · 2009 · 10.1016/j.carres.2009.05.006

  • Structural Basis of the Drug-binding Specificity of Human Serum Albumin

    Journal of Molecular Biology · 2005 · https://doi.org/10.1016/j.jmb.2005.07.075

  • A Molecular Functional Study on the Interactions of Drugs with Plasma Proteins

    Drug Metabolism and Pharmacokinetics · 2005 · 10.2133/dmpk.20.309

  • The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants

    Biochimica et Biophysica Acta (BBA) - General Subjects · 2003 · 10.1016/j.bbagen.2003.08.001

  • Characterization of uremic toxin transport by organic anion transporters in the kidney

    Kidney International · 2003 · https://doi.org/10.1111/j.1523-1755.2004.00354.x

  • The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants

    Biochimica et Biophysica Acta (BBA) - General Subjects · 2003 · 10.1016/j.bbagen.2003.08.001

  • Role of blood–brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain

    Journal of Neurochemistry · 2002 · 10.1046/j.1471-4159.2002.01108.x

  • Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin.

    Biological and Pharmaceutical Bulletin · 2002 · https://doi.org/10.1248/bpb.25.695

  • Pharmaceutical Strategies Utilizing Recombinant Human Serum Albumin

    Pharmaceutical Research · 2002 · 10.1023/a:1015396825274

  • Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-like activity

    Biochemical Journal · 2000 · 10.1042/bj3490813

  • Nitrosothiol Formation Catalyzed by Ceruloplasmin

    Journal of Biological Chemistry · 1999 · 10.1074/jbc.274.38.27069

  • Species Differences of Serum Albumins: I. Drug Binding Sites

    Pharmaceutical Research · 1997 · 10.1023/a:1012138604016

  • Characterization of site I on human serum albumin: concept about the structure of a drug binding site

    Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · 1996 · 10.1016/0167-4838(96)00013-1

  • Study of interaction of carprofen and its enantiomers with human serum albumin—I

    Biochemical Pharmacology · 1993 · 10.1016/0006-2952(93)90576-i

  • Controlled release of indomethacin by chitosan-polyelectrolyte complex: optimization and in vivo/in vitro evaluation

    Journal of Controlled Release · 1993 · 10.1016/0168-3659(93)90080-o

  • Controlled release of indomethacin by chitosan-polyelectrolyte complex: optimization and in vivo/in vitro evaluation

    Journal of Controlled Release · 1993 · 10.1016/0168-3659(93)90080-o

  • Cyclodextrins in drug carrier systems.

    PubMed · 1987

  • Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro.

    Journal of Pharmacobio-Dynamics · 1982 · 10.1248/bpb1978.5.741

  • Inclusi on complexations of steroid hormones with cyclodextrins in water and in solid phase

    International Journal of Pharmaceutics · 1982 · 10.1016/0378-5173(82)90057-6

  • Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro.

    Journal of Pharmacobio-Dynamics · 1982 · 10.1248/bpb1978.5.741

  • The effect of albumin conformation on the binding of warfarin to human serum albumin. The dependence of the binding of warfarin to human serum albumin on the hydrogen, calcium, and chloride ion concentrations as studied by circular dichroism, fluorescence, and equilibrium dialysis.

    Journal of Biological Chemistry · 1980 · 10.1016/s0021-9258(19)85847-7

Current projects

    No projects listed.